"Over the past year, we have reached an important inflection point. We are no longer just discussing the potential of our platform." (CEO, President & Director Najat Khan) "We now have 5 clinical ...

View Recursion Pharmaceuticals stock forecast data, including RXRX stock price estimates and 12-month Recursion Pharmaceuticals price targets, to assess potential upside or downside. Compare RXRX ...

Get the latest news on Recursion Pharmaceuticals stock with updates on market trends, financials, and analysis from Benzinga. Stay informed on Recursion Pharmaceuticals performance ...

Recursion Pharmaceuticals, Inc. is a clinical-stage biotechnology company that combines automation, artificial intelligence, machine learning, and in vivo validation capabilities to discover novel ...